The objective is to provide capital growth.
Name | % Net Assets |
---|---|
Fidelity European Values | 2.1% |
United Technologies Corporation | 1.6% |
Nestle | 1.6% |
GlaxoSmithKline | 1.3% |
Total Capital 4.875% 2010 | 1.2% |
Instituto Credito Official 4.5% 2011 | 1.2% |
European Investment Bank 4.25% 2010 | 1.2% |
BARCLAYS PLC | 1.1% |
BP | 1.1% |
BAE Systems | 1.1% |
Key | % Net Assets |
---|---|
Fidelity European Values | 2.1% |
United Technologies Corporation | 1.6% |
Nestle | 1.6% |
GlaxoSmithKline | 1.3% |
Other | 93.4% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 10/12/2001 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | 100000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 7.50% |
Annual Mang't | 1.85% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.05 |
You are here: research